Ten-year risk for myocardial infarction in patients with first-ever stroke: A community-based study

Acta Neurologica Scandinavica

Volumn 124, Issue 6, 2011, Pages 383-389

  Appelros, P ^a   Gunnarsson, K E ^a   Terent A ^b  

^a ÖREBRO UNIVERSITY HOSPITAL   (Sweden)

^b UPPSALA UNIVERSITY HOSPITAL   (Sweden)

Author keywords

Epidemiology; Myocardial infarction; Prognosis; Stroke; Stroke outcome

Indexed keywords

AGED; ANGINA PECTORIS; ARTICLE; CARDIOVASCULAR RISK; CAROTID ARTERY OBSTRUCTION; CORONARY ARTERY BYPASS GRAFT; FEMALE; HEART INFARCTION; HUMAN; ISCHEMIC HEART DISEASE; MAJOR CLINICAL STUDY; MALE; MORBIDITY; PERCUTANEOUS TRANSLUMINAL ANGIOPLASTY; PERIPHERAL OCCLUSIVE ARTERY DISEASE; STROKE;

ADULT; AGED; AGED, 80 AND OVER; CAROTID STENOSIS; FEMALE; HUMANS; INCIDENCE; KAPLAN-MEIER ESTIMATE; MALE; MIDDLE AGED; MYOCARDIAL INFARCTION; PROGNOSIS; RISK FACTORS; STROKE;

EID: 80054955785     PISSN: 00016314     EISSN: 16000404     Source Type: Journal    
DOI: 10.1111/j.1600-0404.2011.01500.x     Document Type: Article

References (30)

1. Rokey R, Rolak LA, Harati Y, Kutka N, Verani MS. Coronary artery disease in patients with cerebrovascular disease: a prospective study. Ann Neurol 1984;16:50-3.
2. Calvet D, Touzé E, Varenne O, Sablayrolles JL, Weber S, Mas JL. Prevalence of asymptomatic coronary artery disease in ischemic stroke patients: the PRECORIS study. Circulation 2010;121:1623-9.
3. Touzé E, Varenne O, Chatellier G, Peyrard S, Rothwell PM, Mas JL. Risk of myocardial infarction and vascular death after transient ischemic attack and ischemic stroke: a systematic review and meta-analysis. Stroke 2005;36:2748-55.
4. Dhamoon MS, Tai W, Boden-Albala B et al. Risk of myocardial infarction or vascular death after first ischemic stroke: the Northern Manhattan Study. Stroke 2007;38:1752-8.
5. Aho K, Harmsen P, Hatano S, Marquardsen J, Smirnov VE, Strasser T. Cerebrovascular disease in the community: results of a WHO collaborative study. Bull World Health Organ 1980;58:113-30.
6. Sudlow CL, Warlow CP. Comparing stroke incidence worldwide: what makes studies comparable? Stroke 1996;27:550-8.
7. Appelros P, Nydevik I, Seiger Å, Terént A. High incidence rates of stroke in Örebro, Sweden: further support for regional incidence differences within Scandinavia. Cerebrovasc Dis 2002;14:161-8.
8. Bamford J, Sandercock P, Dennis M, Burn J, Warlow C. Classification and natural history of clinically identifiable subtypes of cerebral infarction. Lancet 1991;337:1521-6.
9. Lyden P, Brott T, Tilley B et al. Improved reliability of the NIH Stroke Scale using video training. NINDS TPA Stroke Study Group. Stroke 1994;25:2220-6.
10. The European Carotid Surgery Trialists Collaborative Group. Risk of stroke in the distribution of an asymptomatic carotid artery. Lancet 1995;345:209-12.
11. The National Board of Health and Welfare. Myocardial infarctions in Sweden1987-2007. Stockholm: The National Board of Health and Welfare, 2009. Available from: (accessed 18 February 2010).
12. The National Board of Health and Welfare. National guidelines for coronary heart diseases 2001 (Swedish). Stockholm: The National Board of Health and Welfare, 2001.
13. Alpert JS, Thygesen K, Antman E, Bassand JP. Myocardial infarction redefined--a consensus document of The Joint European Society of Cardiology/American College of Cardiology Committee for the redefinition of myocardial infarction. J Am Coll Cardiol 2000;36:959-69.
14. The National Board of Health and Welfare. Statistical databases - the Swedish AMI statistics. Stockholm: The National Board of Health and Welfare, 2009. Available from: (accessed 26 February 2010).
15. Statistics Sweden. Population statistics. Stockholm: Statistiska Centralbyrån, 2009. Available from: (accessed 25 February 2010).
16. Morris JA, Gardner MJ. Epidemiological studies. In: Altman DG, Machin D, Bryant TN, Gardner MJ, eds. Statistics with confidence, 2nd edn. London: BMJ Books, 2000;57-72.
17. Altman DG, Machin D, Bryant TN, Gardner MJ. Statistics with confidence, 2nd edn. London: BMJ Books, 2000.
18. Dennis M, Bamford J, Sandercock P, Warlow C. Prognosis of transient ischemic attacks in the Oxfordshire Community Stroke Project. Stroke 1990;21:848-53.
19. Viitanen M, Eriksson S, Asplund K. Risk of recurrent stroke, myocardial infarction and epilepsy during long-term follow-up after stroke. Eur Neurol 1988;28:227-31.
20. Kannel WB, Wolf PA, Verter J. Manifestations of coronary disease predisposing to stroke. The Framingham study. JAMA 1983;250:2942-6.
21. Khan U, Porteous L, Hassan A, Markus HS. Risk factor profile of cerebral small vessel disease and its subtypes. J Neurol Neurosurg Psychiatry 2007;78:702-6.
22. Jackson CA, Hutchison A, Dennis MS, Wardlaw JM, Lewis SC, Sudlow CL. Differences between ischemic stroke subtypes in vascular outcomes support a distinct lacunar ischemic stroke arteriopathy: a prospective, hospital-based study. Stroke 2009;40:3679-84.
23. Gongora-Rivera F, Labreuche J, Jaramillo A, Steg PG, Hauw JJ, Amarenco P. Autopsy prevalence of coronary atherosclerosis in patients with fatal stroke. Stroke 2007;38:1203-10.
24. Jackson C, Sudlow C. Comparing risks of death and recurrent vascular events between lacunar and non-lacunar infarction. Brain 2005;128:2507-17.
25. Aichner FT, Topakian R, Alberts MJ et al. High cardiovascular event rates in patients with asymptomatic carotid stenosis: the REACH Registry. Eur J Neurol 2009;16:902-8.
26. Touzé E, Warlow CP, Rothwell PM. Risk of coronary and other nonstroke vascular death in relation to the presence and extent of atherosclerotic disease at the carotid bifurcation. Stroke 2006;37:2904-9.
27. Antithrombotic Trialists' Collaboration. Collaborative meta-analysis of randomised trials of antiplatelet therapy for prevention of death, myocardial infarction, and stroke in high risk patients. BMJ 2002;324:71-86.
28. Arima H, Chalmers J. Secondary prevention of stroke by blood pressure-lowering treatment. Curr Hypertens Rep 2006;8:317-23.
29. Amarenco P, Goldstein LB, Sillesen H et al. Coronary heart disease risk in patients with stroke or transient ischemic attack and no known coronary heart disease: findings from the Stroke Prevention by Aggressive Reduction in Cholesterol Levels (SPARCL) trial. Stroke 2010;41:426-30.
30. Lingsma HF, Steyerberg EW, Scholte op Reimer WJ, Van Domburg R, Dippel DW. Statin treatment after a recent TIA or stroke: is effectiveness shown in randomized clinical trials also observed in everyday clinical practice? Acta Neurol Scand 2010;122:15-20.